E. Ohman J:or Asset Management’s Moderna MRNA Stock Holding History

E. Ohman J:or Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14,100	Closed	-$400K	–	414
2025 Q1	$400K	Hold	14,100	–	–	0.01%	398
2024 Q4	$586K	Hold	14,100	–	–	0.01%	361
2024 Q3	$942K	Buy	+14,100	New	+$1.29M	0.02%	265
2021 Q2	–	Sell	-55,700	Closed	-$7.29M	–	471
2021 Q1	$7.29M	Buy	55,700 +12,100	+28%	+$1.75M	0.26%	68
2020 Q4	$4.55M	Sell	43,600 -23,500	-35%	-$2.38M	0.19%	82
2020 Q3	$4.75M	Sell	67,100 -5,700	-8%	-$397K	0.23%	71
2020 Q2	$4.67M	Buy	72,800 +18,600	+34%	+$1.02M	0.27%	59
2020 Q1	$1.62M	Buy	54,200 +2,900	+6%	+$66.7K	0.12%	96
2019 Q4	$1M	Buy	51,300 +11,300	+28%	+$200K	0.06%	201
2019 Q3	$637K	Buy	+40,000	New	+$591K	0.04%	217

Other funds holding MRNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

E. Ohman J:or Asset Management's MRNA Position: Q2 2025 in Review

E. Ohman J:or Asset Management sold out of Moderna (MRNA) in Q2 2025, closing a stake of 14,100 shares — an estimated $400K sold.

E. Ohman J:or Asset Management first reported a position in MRNA in Q3 2019 and held it in 10 quarters. The position peaked at $7.29M in Q1 2021. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

E. Ohman J:or Asset Management reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
E. Ohman J:or Asset Management sold 14,100 Moderna shares in Q2 2025, an estimated $400K.
E. Ohman J:or Asset Management first reported a position in Moderna in Q3 2019 and held it in 10 quarters.
E. Ohman J:or Asset Management's Moderna position peaked at $7.29M in Q1 2021.
674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2025, filed 8 Jul 2025.